Another Live Blog on the FDA Sickle Cell Hearing; This One from BioPharma Dive
Joseph Wu of Stanford, Alexis Komor of UC San Diego quoted
BioPharma Dive is also live-blogging today’s FDA hearing on the gene therapy for sickle cell disease. Here is their latest posting.
“Enemy of the good
“The committee has ended its cross-examination of Vertex and moved on to the broader discussion. Scot Wolfe, professor of molecular, cell, and cancer biology at the University of Massachusetts medical scho…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.